201 related articles for article (PubMed ID: 23034582)
1. Clobazam : in patients with Lennox-Gastaut syndrome.
Yang LP; Scott LJ
CNS Drugs; 2012 Nov; 26(11):983-91. PubMed ID: 23034582
[TBL] [Abstract][Full Text] [Related]
2. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
[TBL] [Abstract][Full Text] [Related]
3. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome.
Ng YT; Conry JA; Drummond R; Stolle J; Weinberg MA;
Neurology; 2011 Oct; 77(15):1473-81. PubMed ID: 21956725
[TBL] [Abstract][Full Text] [Related]
4. The use of clobazam as an adjunctive treatment for Lennox-Gastaut syndrome.
Owen RT
Drugs Today (Barc); 2012 Nov; 48(11):697-703. PubMed ID: 23170305
[TBL] [Abstract][Full Text] [Related]
5. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: interim results of an open-label extension study.
Ng YT; Conry J; Paolicchi J; Kernitsky L; Mitchell W; Drummond R; Isojarvi J; Lee D; Owen R;
Epilepsy Behav; 2012 Dec; 25(4):687-94. PubMed ID: 23141144
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome.
Tolbert D; Harris SI; Bekersky I; Lee D; Isojarvi J
Epilepsy Behav; 2014 Aug; 37():11-5. PubMed ID: 24949576
[TBL] [Abstract][Full Text] [Related]
8. Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome.
Paolicchi JM; Ross G; Lee D; Drummond R; Isojarvi J
Pediatr Neurol; 2015 Oct; 53(4):338-42. PubMed ID: 26245776
[TBL] [Abstract][Full Text] [Related]
9. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
Cramer JA; Sapin C; François C
Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
[TBL] [Abstract][Full Text] [Related]
10. Clobazam approved for seizure disorder.
Traynor K
Am J Health Syst Pharm; 2011 Dec; 68(23):2204. PubMed ID: 22095800
[No Abstract] [Full Text] [Related]
11. Clobazam for patients with Lennox-Gastaut syndrome and epilepsy.
Seif-Eddeine H; Ng YT
Expert Rev Neurother; 2012 Apr; 12(4):385-93. PubMed ID: 22449211
[TBL] [Abstract][Full Text] [Related]
12. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
McCormack PL
Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
[TBL] [Abstract][Full Text] [Related]
13. Clobazam (Onfi) for Lennox-Gastaut syndrome.
Med Lett Drugs Ther; 2012 Mar; 54(1385):18-9. PubMed ID: 22382580
[No Abstract] [Full Text] [Related]
14. Clobazam-treated patients with Lennox-Gastaut syndrome experienced fewer seizure-related injuries than placebo patients during trial OV-1012.
Isojarvi J; Lee D; Peng G; Sperling MR
Epilepsia; 2016 Jun; 57(6):e113-6. PubMed ID: 27145465
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
[TBL] [Abstract][Full Text] [Related]
16. Optimizing clobazam treatment in patients with Lennox-Gastaut syndrome.
Isojarvi J; Gidal BE; Chung S; Wechsler RT
Epilepsy Behav; 2018 Jan; 78():149-154. PubMed ID: 29202277
[TBL] [Abstract][Full Text] [Related]
17. Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study.
Gidal BE; Wechsler RT; Sankar R; Montouris GD; White HS; Cloyd JC; Kane MC; Peng G; Tworek DM; Shen V; Isojarvi J
Neurology; 2016 Oct; 87(17):1806-1812. PubMed ID: 27683846
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ
Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
[No Abstract] [Full Text] [Related]
19. Clobazam, ezogabine, and tafluprost.
Hussar DA; Hallinan SE
J Am Pharm Assoc (2003); 2012; 52(4):546-50. PubMed ID: 22825237
[No Abstract] [Full Text] [Related]
20. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
Lee EH; Yum MS; Choi HW; Ko TS
Clin Neuropharmacol; 2013; 36(1):4-7. PubMed ID: 23334068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
